User Reviews for Eculizumab
Also known as: Soliris
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Myasthenia Gravis | 1 reviews | 9 medications | |
| Paroxysmal Nocturnal Hemoglobinuria | 1 reviews | 3 medications | |
| Summary of Eculizumab reviews | 5.0 | 2 reviews | |
Reviews may be edited to correct grammar/spelling, or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published.
Nick
·
Taken for 1 to 6 months
July 10, 2019
Soliris (eculizumab) for Myasthenia Gravis: “I started taking SOLIRIS January 2019 and by July 2019 I had throat cancer which was undetectable by CT scan but was confirmed by tissue biopsy.”
This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge and judgement of healthcare professionals.
More about eculizumab
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- Compare Alternatives
- En Español
- Drug class: selective immunosuppressants
Patient resources
- Other brands
- Soliris
Soliris (eculizumab) for Paroxysmal Nocturnal Hemoglobinuria: “This drug is for Paroxysmal Nocturnal Hemoglobinuria (PNH) but disease is heterogeneous. I feel worse being on it. Doctors push it-patients just do it. It is too much work. I never should have started.”